Corrigendum to 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial' [Vaccine 36 (2018) 4278–4286]. Issue 9 (21st February 2019) - Maréchal, Céline; Lal, Himal; Poder, Airi; Ferguson, Murdo; Enweonye, Igwebuike; Heineman, Thomas C.; Hervé, Caroline; Rheault, Paul; Talli, Jaak; Wauters, Dominique; Oostvogels, Lidia